Australia markets open in 1 hour 28 minutes

Wave Life Sciences Ltd. (WVE)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
6.14+0.26 (+4.42%)
At close: 04:00PM EDT
6.14 0.00 (0.00%)
After hours: 04:05PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 751.04M
Enterprise value 582.80M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)5.75
Price/book (mrq)18.95
Enterprise value/revenue 5.14
Enterprise value/EBITDA -9.91

Trading information

Stock price history

Beta (5Y monthly) -1.08
52-week change 347.74%
S&P500 52-week change 322.38%
52-week high 37.67
52-week low 33.15
50-day moving average 35.61
200-day moving average 35.08

Share statistics

Avg vol (3-month) 3906k
Avg vol (10-day) 3597.31k
Shares outstanding 5122.32M
Implied shares outstanding 6122.32M
Float 867.25M
% held by insiders 118.20%
% held by institutions 175.16%
Shares short (15 Apr 2024) 43.15M
Short ratio (15 Apr 2024) 43.8
Short % of float (15 Apr 2024) 43.76%
Short % of shares outstanding (15 Apr 2024) 42.58%
Shares short (prior month 15 Mar 2024) 43M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -50.76%
Operating margin (ttm)-64.30%

Management effectiveness

Return on assets (ttm)-20.17%
Return on equity (ttm)-1,118.17%

Income statement

Revenue (ttm)113.31M
Revenue per share (ttm)1.07
Quarterly revenue growth (yoy)2,245.10%
Gross profit (ttm)N/A
EBITDA -63M
Net income avi to common (ttm)-57.51M
Diluted EPS (ttm)-0.54
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)200.35M
Total cash per share (mrq)1.64
Total debt (mrq)32.12M
Total debt/equity (mrq)67.61%
Current ratio (mrq)1.26
Book value per share (mrq)0.33

Cash flow statement

Operating cash flow (ttm)-19.43M
Levered free cash flow (ttm)64.11M